197 related articles for article (PubMed ID: 9300669)
21. Nonviral skin gene therapy.
Vogel JC
Hum Gene Ther; 2000 Nov; 11(16):2253-9. PubMed ID: 11084683
[TBL] [Abstract][Full Text] [Related]
22. Targeted single-base correction by RNA-DNA oligonucleotides.
Igoucheva O; Yoon K
Hum Gene Ther; 2000 Nov; 11(16):2307-12. PubMed ID: 11084691
[TBL] [Abstract][Full Text] [Related]
23. A phase I study of adenovirus mediated gene transfer of interleukin 2 cDNA into metastatic breast cancer or melanoma.
Stewart AK; Lassam NJ; Graham FL; Gauldie J; Addison CL; Bailey DJ; Dessureault S; Dubé ID; Gallenger S; Krajden M; Rotstein LE; Quirt IC; Moen R
Hum Gene Ther; 1997 Jul; 8(11):1403-14. PubMed ID: 9295135
[No Abstract] [Full Text] [Related]
24. Basic concepts, current evidence, and future potential for gene therapy in managing cutaneous wounds.
Oryan A; Alemzadeh E; Zarei M
Biotechnol Lett; 2019 Sep; 41(8-9):889-898. PubMed ID: 31256273
[TBL] [Abstract][Full Text] [Related]
25. Gene therapy for tissue repair: approaches and prospects.
Eming SA; Morgan JR; Berger A
Br J Plast Surg; 1997 Oct; 50(7):491-500. PubMed ID: 9422946
[TBL] [Abstract][Full Text] [Related]
26. Generating and regulating immune responses through cutaneous gene delivery.
Larregina AT; Falo LD
Hum Gene Ther; 2000 Nov; 11(16):2301-5. PubMed ID: 11084690
[TBL] [Abstract][Full Text] [Related]
27. Cutaneous gene therapy. Principles and prospects.
Lin MT; Pulkkinen L; Uitto J
Dermatol Clin; 2000 Jan; 18(1):177-88, xi. PubMed ID: 10626123
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous gene transfer and therapy: the present and the future.
Spirito F; Meneguzzi G; Danos O; Mezzina M
J Gene Med; 2001; 3(1):21-31. PubMed ID: 11269332
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous gene therapy.
Khavari PA; Krueger GG
Dermatol Clin; 1997 Jan; 15(1):27-35. PubMed ID: 9001858
[TBL] [Abstract][Full Text] [Related]
30. Recombinant adeno-associated virus type 2-mediated gene transfer into human keratinocytes is influenced by both the ubiquitin/proteasome pathway and epidermal growth factor receptor tyrosine kinase.
Braun-Falco M; Eisenried A; Büning H; Ring J
Arch Dermatol Res; 2005 May; 296(11):528-35. PubMed ID: 15776248
[TBL] [Abstract][Full Text] [Related]
31. In vivo transduction of mouse epidermis with recombinant retroviral vectors: implications for cutaneous gene therapy.
Ghazizadeh S; Harrington R; Taichman L
Gene Ther; 1999 Jul; 6(7):1267-75. PubMed ID: 10455435
[TBL] [Abstract][Full Text] [Related]
32. Sustainable cutaneous gene delivery.
Deng H; Lin Q; Khavari PA
Nat Biotechnol; 1997 Dec; 15(13):1388-91. PubMed ID: 9415892
[TBL] [Abstract][Full Text] [Related]
33. Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines.
Bramson J; Dayball K; Evelegh C; Wan YH; Page D; Smith A
Gene Ther; 2003 Feb; 10(3):251-60. PubMed ID: 12571633
[TBL] [Abstract][Full Text] [Related]
34. Epidermal stem cells as targets for gene transfer.
Watt FM
Hum Gene Ther; 2000 Nov; 11(16):2261-6. PubMed ID: 11084684
[TBL] [Abstract][Full Text] [Related]
35. Somatic gene therapy and its implications in melanoma treatment.
Möller P; Schadendorf D
Arch Dermatol Res; 1997 Jan; 289(2):71-7. PubMed ID: 9049039
[No Abstract] [Full Text] [Related]
36. Current treatments for advanced melanoma and introduction of a promising novel gene therapy for melanoma (Review).
Heo JR; Kim NH; Cho J; Choi KC
Oncol Rep; 2016 Oct; 36(4):1779-86. PubMed ID: 27573048
[TBL] [Abstract][Full Text] [Related]
37. Gene transfer by electrical fields.
Rols MP
Curr Gene Ther; 2010 Aug; 10(4):255. PubMed ID: 20718698
[No Abstract] [Full Text] [Related]
38. Particle-mediated gene therapy of wounds.
Davidson JM; Krieg T; Eming SA
Wound Repair Regen; 2000; 8(6):452-9. PubMed ID: 11208172
[TBL] [Abstract][Full Text] [Related]
39. Direct cutaneous gene delivery in a human genetic skin disease.
Choate KA; Khavari PA
Hum Gene Ther; 1997 Sep; 8(14):1659-65. PubMed ID: 9322868
[TBL] [Abstract][Full Text] [Related]
40. Long-term engraftment of single genetically modified human epidermal holoclones enables safety pre-assessment of cutaneous gene therapy.
Larcher F; Dellambra E; Rico L; Bondanza S; Murillas R; Cattoglio C; Mavilio F; Jorcano JL; Zambruno G; Del Rio M
Mol Ther; 2007 Sep; 15(9):1670-6. PubMed ID: 17579576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
